Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free AVTX Stock Alerts $12.81 +0.60 (+4.91%) (As of 03:58 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. Avalo Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.91) EPSNext Year EPS Consensus Estimate: ($0.97) EPSAVTX Earnings Date and InformationAvalo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.Read More Get Avalo Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AVTX and its competitors with MarketBeat's FREE daily newsletter. Avalo Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Estimated)------- 11/9/2023Q3 2023($264.00)($26.40)+$237.60($0.11)$1.00 million$0.24 million8/3/2023Q2 2023($216.00)($141.60)+$74.40($0.59)$1.00 million$0.64 million5/4/2023Q1 2023($232.80)($204.00)+$28.80($0.85)$1.00 million$0.48 million3/29/2023Q4 2022($124.80)($249.60)($124.80)($1.04)$5.20 million$0.90 million11/7/2022Q3 2022($247.20)$81.60+$328.80$0.34$1.40 million$14.95 million8/4/2022Q2 2022($432.00)($331.20)+$100.80($1.38)-$1.03 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/5/2022Q1 2022($33.60)($48.00)($14.40)($0.20)-$1.17 million3/2/2022Q4 2021($432.00)($460.80)($28.80)---11/9/2021Q3 2021($518.40)($489.60)+$28.80($0.17)-$1.35 million8/2/2021Q2 2021($518.40)($518.40)-($0.18)-$3.36 million5/13/2021Q1 2021($662.40)($921.60)($259.20)($0.32)-$0.47 million Avalo Therapeutics Earnings - Frequently Asked Questions When is Avalo Therapeutics's earnings date? Avalo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on AVTX's earnings history. How much revenue does Avalo Therapeutics generate each year? Avalo Therapeutics (NASDAQ:AVTX) has a recorded annual revenue of $1.92 million. How much profit does Avalo Therapeutics generate each year? Avalo Therapeutics (NASDAQ:AVTX) has a recorded net income of -$31.54 million. AVTX has generated -$616.67 earnings per share over the last four quarters. What is Avalo Therapeutics's EPS forecast for next year? Avalo Therapeutics's earnings are expected to decrease from ($0.91) per share to ($0.97) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Aytu BioPharma Earnings Results Pieris Pharmaceuticals Earnings Results NeuroBo Pharmaceuticals Earnings Results Orgenesis Earnings Results Talphera Earnings Results Minerva Neurosciences Earnings Results Cocrystal Pharma Earnings Results VBI Vaccines Earnings Results Galecto Earnings Results Kiora Pharmaceuticals Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:AVTX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersIs Tesla going out of business?DTI Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
